IRADIMED CORP (IRMD) Stock Income Statement
NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 75.15M | 73.24M | 65.56M | 53.30M | 41.81M | |||
| Cost Of Goods | 17.35M | 16.89M | 15.40M | 12.02M | 9.76M | |||
| Gross Profit | 57.80M | 56.35M | 50.16M | 41.28M | 32.05M | |||
| Operating Expenses | 35.16M | 34.39M | 30.12M | 25.66M | 22.24M | |||
| Research and Development | 2.63M | 2.83M | 2.86M | 2.28M | 1.91M | |||
| Selling, General, and Administrative Expenses | 32.52M | 31.55M | 27.26M | 23.38M | 20.33M | |||
| Operating Income | 22.65M | 21.96M | 20.04M | 15.63M | 9.82M | |||
| Interest Income/Expense | N/A | 2.15M | 1.72M | 550.00K | 20.00K | |||
| Other Income/Expense | 2.33M | 164.40K | 1.70M | 553.10K | 20.00K | |||
| Income Before Taxes | 24.98M | 24.28M | 21.74M | 16.18M | 9.84M | |||
| Income Tax | 5.19M | 5.04M | 4.55M | 3.35M | 510.00K | |||
| Net Income | 19.78M | 19.23M | 17.19M | 12.83M | 9.33M | |||
| EBITDA | 23.43M | 22.78M | 20.80M | 16.30M | 11.23M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.55 | 1.50 | 1.35 | 1.02 | 0.74 | |||
| Non GAAP EPS | 1.71 | 1.65 | 1.48 | 1.09 | 0.83 | |||
| Statistics | ||||||||
| Gross Profit Margin | 76.91% | 76.94% | 76.50% | 77.45% | 76.66% | |||
| Profit Margin | 26.33% | 26.26% | 26.22% | 24.07% | 22.32% | |||
| Operating Profit Margin | 30.14% | 29.99% | 30.56% | 29.32% | 23.49% | |||
All data in USD